KEIGO YATO

Venture Capitalist

PROFILE

Engaged in research on hepatitis vaccines and immune response to viruses at the National Institute of Infectious Diseases. While studying for his doctorate, he felt a great challenge in implementing the seeds of academia into society, and joined Beyond Next Ventures as a student intern, and since April 2022, he engages in investment in the biotechnology and drug discovery fields as a full-time employee. He hopes to improve the research environment in Japan and enrich the world with Japanese technology.

Facebook Twitter
KEIGO YATO